Bioventus Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bioventus Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
  • Bioventus Inc. Operating Income (Loss) for the quarter ending June 29, 2024 was -$29.4M, a 535% decline year-over-year.
  • Bioventus Inc. Operating Income (Loss) for the twelve months ending June 29, 2024 was -$20.5M, a 91% increase year-over-year.
  • Bioventus Inc. annual Operating Income (Loss) for 2023 was -$81.7M, a 51.1% increase from 2022.
  • Bioventus Inc. annual Operating Income (Loss) for 2022 was -$167M, a 1487% decline from 2021.
  • Bioventus Inc. annual Operating Income (Loss) for 2021 was $12.1M, a 43.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$20.5M -$29.4M -$36.1M -535% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $15.7M $5.33M +$97.4M Jan 1, 2024 Mar 30, 2024 10-Q 2024-05-07
Q4 2023 -$81.7M $1.17M +$16.8M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$98.5M $2.42M +$129M Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$228M $6.75M +$10.1M Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 -$238M -$92.1M -$70.6M -329% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 -$167M -$15.6M -$12.5M -396% Oct 2, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$155M -$127M -$126M -12015% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 -$29M -$3.31M +$2.43M +42.4% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 -$31.4M -$21.5M -$43.4M -198% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-16
Q4 2021 $12.1M -$3.15M -$9.06M -153% Oct 3, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 $21.1M -$1.05M -$7.98M -115% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-21
Q2 2021 $29.1M -$5.74M -$1.15M -25% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-12
Q1 2021 $30.2M $22M +$9.01M +69.4% Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $21.2M $5.91M Sep 27, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $6.93M Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 -$4.59M Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $13M Jan 1, 2020 Mar 28, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.